Status:
UNKNOWN
Possible Epigenetic Changes in Offspring of Women With Pregestational and Gestational Diabetes
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Gestational Diabetes
Pregestational Diabetes
Eligibility:
All Genders
Brief Summary
Pregestational diabetes (PGD) during pregnancy may be associated with an increased rate of spontaneous abortions, intrauterine death and congenital anomalies among the offspring. Although the prevalen...
Eligibility Criteria
Inclusion
- Infants born to women suffering from pre-gestational or gestational diabetes.
Exclusion
- Non Jewish population
- Triplets and up
- Premature infants under 32 weeks
- Infants suffering from major congenital anomalies
- Infants with chromosomal aberrations
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01255384
Start Date
December 1 2010
Last Update
December 7 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization, Jerusalem, Israel
Jerusalem, Israel